In terms of the relevance of TMEM16F to the thrombin-activated platelets, hereditary mutations in TMEM16F have been identified in patients with Scott syndrome, a rare bleeding disorder whereby coagulation is impaired by the lack of calcium-mediated PS externalization on the platelet membranes [102, 112]. Here, ANO6 is linked to hemorrhagic disease.